Doc1 Healthcare Systems

Chino, California 91710

0 studies enrolling now · 2 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis

Studies at this site

• A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) — Completed
• A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata — Running, not enrolling